• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Merck

Anonymous board for Merck

Sticky threads

Normal threads

Replies
254
Views
81K
anonymous
Replies
2
Views
308
Replies
59
Views
15K
Replies
0
Views
392
anonymous
Replies
1
Views
590
anonymous
Replies
197
Views
44K
anonymous
Replies
6
Views
1K
anonymous
Replies
5
Views
754
anonymous
Replies
18
Views
8K
anonymous
Replies
18
Views
4K
anonymous
Replies
9
Views
3K
anonymous
Replies
7
Views
805
anonymous
Replies
10
Views
3K
anonymous
Replies
97
Views
26K
anonymous
Replies
5
Views
2K
anonymous
Replies
23
Views
5K
anonymous
Replies
1
Views
477
anonymous